Opportunity PA-07-174

Applicants Eligible for this Grant

State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)

Additional Information on Eligibility

Foreign institutions are eligible to apply.

Grant Description

-Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to stimulate multidisciplinary research on potential reduced-exposure tobacco products, both smoked and smokeless, through the interplay of basic, biological, and behavioral research, surveillance, and epidemiology. The tobacco industry is currently promoting some new products with claims that they are less harmful or less addictive because these products purportedly deliver lower amounts of toxic, carcinogenic, and/or addictive agents to the user compared with conventional products. However, to date, the scientific evidence is insufficient to evaluate whether these new products actually reduce the users exposure or risk for tobacco-related diseases. The key research question of this FOA is, Do potential reduced-exposure tobacco products provide a truly, less-harmful alternative to conventional tobacco products, both on the individual and population level? -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism and runs in parallel with an FOA of identical scientific scope, PA-06-361, that solicits applications under the NIH Exploratory/Developmental Grant (R21) grant mechanism. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

Link to Full Grant Announcement

http://grants.nih.gov/grants/guide/pa-files/pa-07-174.html

Grant Announcement Contact

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]

Similar Government Grants

• NIDA Research Center of Excellence Grant Program (P50)

• Substance Use Disorders and Molecular Regulation of Brain Energy Utilization (R21)

• Substance Use Disorders and Molecular Regulation of Brain Energy Utilization (R01)

• Medications Development Centers of Excellence Cooperative Program (U54)

• Drug Abuse Dissertation Research (R36)

• NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards

• Drug Abuse Aspects of Hiv/Aids and Other Infections

• Epidemiology of Drug Abuse

More Grants from the National Institutes of Health

• Innovative Approaches and Technologies for Examining the Uncultivable Bacteria of the Oral...

• Research on the Role of Epigenetics in Social, Behavioral, Environmental and Biological Re...

• Pediatric Critical Care and Trauma Scientist Development Program (K12)

• Evidence-based Demonstration Projects in Immunization (Admin Supp)

• Biomarkers for Diabetes, Digestive, Kidney and Urologic Diseases Using Biosamples from the...